Q32 Bio Inc.: shareholders and insiders

QTTBNASDAQHealthcare · Pharmaceutical Preparations

Price

$8.34

November 20, 2026Market cap $250M

What Ploutos Investor adds for Q32 Bio

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 8 fiscal years, from 2018
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • Earnings per share here are the last twelve months' earnings over today's shares, so they agree with the P/E. The number of shares changed a lot during the year, so they differ from the earnings per share the company filed, which use the year's average number of shares.

Insiders and their shares

Purchases and sales by officers and directors, from their own Form 4 filings.

Reading the newest filings from the SEC. This part fills in on its own in a few seconds.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

7 Holders over 5%1 On a 13DNov 6, 2026 Latest filing
  • Orbimed Advisorswith 2 more persons
    Share of class13.9%
  • Biotechnology Value Fund L Pwith 9 more persons
    Share of class9.99%
  • RA Capital Management, L.P.with 3 more persons
    Share of class9.80%
  • Boxer Capital Management, LLCwith 3 more persons
    Share of class7.90%
  • Bank of America
    Share of class7.40%
  • Frazier Life Sciences Public Fund, L.P.with 5 more persons
    Share of class5.90%
  • ADAR1 Partners, LPwith 3 more persons
    Share of class5.40%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • Orbimed Advisors13.9%From the filing of Jul 20, 2026

    The Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Issuer's Shares in particular, as well as other developments and other investment opportunities. Based upon such review, the Reporting Persons will take such actions in the future as the Reporting Persons may deem appropriate in light of the circumstances existing from time to time. If the Reporting Persons believe that further investment in the Issuer is attractive, whether because of the…

    From the filing of Jul 20, 2026
Fell to 5% or less (8)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Opaleye Management Inc.3.76%Nov 6, 202613G/A
  • Point72 Asset Management, L.P.4.95%Aug 14, 202613G/A
  • Sirenia Capital Management LP0.00%Aug 14, 202613G/A
  • The Carlyle Group Inc.4.10%Jul 6, 202613G/A
  • Atlas Venture Fund X, L.P.13D3.60%May 28, 202613D/A
  • Pfizer Inc. (IRS Identification No.: 13-5315170)2.30%Feb 13, 202613G/A
  • Sio Capital Management, LLC0.00%Apr 8, 202513G
  • Bristol Myers Squibb1.64%Feb 14, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter-71%
  • Citadel Advisors (Griffin)
    In the quarter+417%
  • Millennium Mgmt (Englander)
    In the quarter×22.7
  • Renaissance Technologies
    In the quarter-61%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 18.9% of its shares outstanding were held short, +21.0% since the report before.

Shares held short
5.65M
18.9%
Since the report before4.67M on Sep 30, 2026
+21.0%
5.3
1.08M
More days to cover thanof 4,578 US-listed companies with enough volume
63%
Report date
Oct 15, 2026
  • Mar 28, 2024: Shares held short 10.3K
  • Apr 15, 2024: Shares held short 13.0K
  • Apr 30, 2024: Shares held short 21.8K
  • May 15, 2024: Shares held short 31.7K
  • May 31, 2024: Shares held short 60.1K
  • Jun 14, 2024: Shares held short 44.6K
  • Jun 28, 2024: Shares held short 64.9K
  • Jul 15, 2024: Shares held short 263.0K
  • Jul 31, 2024: Shares held short 275.4K
  • Aug 15, 2024: Shares held short 313.1K
  • Aug 30, 2024: Shares held short 364.6K
  • Sep 13, 2024: Shares held short 478.0K
  • Sep 30, 2024: Shares held short 608.2K
  • Oct 15, 2024: Shares held short 678.6K
  • Oct 31, 2024: Shares held short 686.1K
  • Nov 15, 2024: Shares held short 625.3K
  • Nov 29, 2024: Shares held short 719.1K
  • Dec 13, 2024: Shares held short 1.12M
  • Dec 31, 2024: Shares held short 1.47M
  • Jan 15, 2025: Shares held short 1.34M
  • Jan 31, 2025: Shares held short 1.34M
  • Feb 14, 2025: Shares held short 1.31M
  • Feb 28, 2025: Shares held short 1.03M
  • Mar 14, 2025: Shares held short 1.01M
  • Mar 31, 2025: Shares held short 868.5K
  • Apr 15, 2025: Shares held short 703.2K
  • Apr 30, 2025: Shares held short 554.2K
  • May 15, 2025: Shares held short 627.0K
  • May 30, 2025: Shares held short 459.6K
  • Jun 13, 2025: Shares held short 384.8K
  • Jun 30, 2025: Shares held short 266.1K
  • Jul 15, 2025: Shares held short 556.8K
  • Jul 31, 2025: Shares held short 412.2K
  • Aug 15, 2025: Shares held short 355.9K
  • Aug 29, 2025: Shares held short 306.9K
  • Sep 15, 2025: Shares held short 288.5K
  • Sep 30, 2025: Shares held short 277.8K
  • Oct 15, 2025: Shares held short 464.5K
  • Oct 31, 2025: Shares held short 272.9K
  • Nov 14, 2025: Shares held short 277.8K
  • Nov 28, 2025: Shares held short 295.2K
  • Dec 15, 2025: Shares held short 428.9K
  • Dec 31, 2025: Shares held short 282.0K
  • Jan 15, 2026: Shares held short 264.9K
  • Jan 30, 2026: Shares held short 308.7K
  • Feb 13, 2026: Shares held short 365.6K
  • Feb 27, 2026: Shares held short 362.0K
  • Mar 13, 2026: Shares held short 350.5K
  • Mar 31, 2026: Shares held short 411.0K
  • Apr 15, 2026: Shares held short 382.4K
  • Apr 30, 2026: Shares held short 652.8K
  • May 15, 2026: Shares held short 632.7K
  • May 29, 2026: Shares held short 861.7K
  • Jun 15, 2026: Shares held short 906.2K
  • Jun 30, 2026: Shares held short 677.0K
  • Jul 15, 2026: Shares held short 2.26M
  • Jul 31, 2026: Shares held short 3.00M
  • Aug 14, 2026: Shares held short 3.14M
  • Aug 31, 2026: Shares held short 3.56M
  • Sep 15, 2026: Shares held short 3.77M
  • Sep 30, 2026: Shares held short 4.67M
  • Oct 15, 2026: Shares held short 5.65M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading55.5% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 55.5% of the shares in the reported trades were short sales, against 51.4% in the 14 before.

Last 14 sessionsNov 2, 2026 – Nov 19, 2026
55.5%
The 14 beforeOct 13, 2026 – Oct 30, 2026
51.4%
Change
+4.1 pts
Short sales a dayon average, of 125.3K shares
69.5K
More than atof 3,666 US-listed companies, same days
69%
Median of alleight in ten from 34.5% to 63.8%
50.4%
  • Oct 13, 2026: Short sales 68.1%
  • Oct 14, 2026: Short sales 56.4%
  • Oct 15, 2026: Short sales 45.1%
  • Oct 16, 2026: Short sales 53.2%
  • Oct 19, 2026: Short sales 53.9%
  • Oct 20, 2026: Short sales 50.9%
  • Oct 21, 2026: Short sales 41.9%
  • Oct 22, 2026: Short sales 59.8%
  • Oct 23, 2026: Short sales 49.7%
  • Oct 26, 2026: Short sales 51.4%
  • Oct 27, 2026: Short sales 38.5%
  • Oct 28, 2026: Short sales 40.7%
  • Oct 29, 2026: Short sales 48.5%
  • Oct 30, 2026: Short sales 58.8%
  • Nov 2, 2026: Short sales 61.7%
  • Nov 3, 2026: Short sales 72.1%
  • Nov 4, 2026: Short sales 72.2%
  • Nov 5, 2026: Short sales 56%
  • Nov 6, 2026: Short sales 57.2%
  • Nov 9, 2026: Short sales 62.2%
  • Nov 10, 2026: Short sales 59.1%
  • Nov 11, 2026: Short sales 42.9%
  • Nov 12, 2026: Short sales 53.7%
  • Nov 13, 2026: Short sales 64.8%
  • Nov 16, 2026: Short sales 66.9%
  • Nov 17, 2026: Short sales 33.6%
  • Nov 18, 2026: Short sales 43.1%
  • Nov 19, 2026: Short sales 58.7%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

6 ETFs holding it0.02% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.02%
  • AVUVAvantis U.S. Small Cap Value ETF
    Weight in the fund0.02%
  • AVUSAvantis U.S. Equity ETF
    Weight in the fund0.00%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • DFASDimensional U.S. Small Cap ETF
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

6 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

71 Managers, Q2 2026$283M Value of their positions
  • Q3 2025: Managers 53
  • Q4 2025: Managers 52
  • Q1 2026: Managers 53
  • Q2 2026: Managers 71

Institutional investors by quarter

The fund managers holding QTTB, quarter by quarter, from Q1 2024 to Q2 2025, 6 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 10 quarters.

Q2 2026: 71 managers held 22.20M shares, worth $283M. During the quarter 27 opened a position, 9 closed one, 16 added and 13 trimmed.

The largest holders, Q2 2026

  • Orbimed Advisors
    In the quarter+83%
  • Boxer Capital Management
    In the quarter
  • Atlas Venture Life Science Advisors
    In the quarter+30%
  • Bvf
    In the quarter
  • Ra Capital Management
    In the quarter
  • Point72 (Cohen)
    In the quarter
  • Opaleye Management
    In the quarter-26%
  • Logos Global Management
    In the quarter
  • SummitTX Capital
    In the quarter
  • Vanguard Capital Management
    In the quarter+69%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Q32 Bio's filings show?

Who buys and sells is one part of Q32 Bio's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about QTTB's shareholders

Didn't find what you were looking for?

Ask us
Which well-known managers hold QTTB?

4 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $5.2M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.